High Bolus Dose Tirofiban and Enoxaparin Provides Reduced Thrombin Generation and Inflammatory Markers in Patients With High Risk Undergoing Percutaneous Intervention.
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2010
At a glance
- Drugs Enoxaparin sodium; Heparin; Tirofiban
- Indications Acute coronary syndromes; Coronary thrombosis
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 27 Nov 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History